Versigent earnings release, August 4, 2026

Versigent PLC (VGNT) · Form 8-K, Item 2.02 · Filed · SEC filing

PRESS RELEASE

Versigent Reports Second Quarter 2026 Results

Delivers 11% Net Sales Growth; Raises and Tightens Full-Year 2026 Net Sales Guidance;

Initiates Quarterly Dividend

SCHAFFHAUSEN, Switzerland, August 4, 2026 – Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low‑ and high‑voltage electrical architectures, today reported results for its second quarter ended June 30, 2026.

Highlights

Second Quarter 2026

• Net sales of $2,444 million, up 10.8% year-over-year

◦ Adjusted Net Sales Growth¹ of approximately 5% year-over-year

• Net income attributable to Versigent of $118 million, up 10.3% year-over-year

• Diluted Earnings Per Share of $1.64, Adjusted Diluted EPS¹ of $1.92

• Adjusted EBITDA¹ of $272 million, up 24.8% year-over-year

◦ Adjusted EBITDA¹ margin of 11.1%, up 120 basis points year-over-year

• Net cash provided by operating activities of $158 million, compared to $150 million in Q2 2025

• Free Cash Flow¹ of $107 million, relatively flat year-over-year

• Board of Directors declared inaugural quarterly cash dividend of $0.13 per share

Full Year 2026 Guidance

• Raised and tightened net sales guidance based on higher commodity pass-throughs and foreign currency impacts

• Reaffirmed guidance for Adjusted EBITDA¹ and Free Cash Flow¹

“Versigent’s solid second-quarter results demonstrate our continued ability to unlock greater value, even in a dynamic environment,” said Joseph Liotine, Chief Executive Officer, Versigent. “Customers trust our ability to turn complexity into certainty. This is reflected in our strong net sales growth, evidenced by our expanding book of business and earned every day by our deep commitment to disciplined execution. Strategic investments in advanced engineering, operational excellence and an in-region, for-region supply chain fortifies our long-term competitive position as a proven innovator defining the future of advanced power and data solutions.”

"Our double-digit net sales growth, underpinned by strong margins and cash generation, reflects the strength of our business and the value of our differentiated capabilities,” said Doug Ostermann, Chief Financial Officer, Versigent. “We are off to a strong start as an independent company and based on our performance to date and outlook for the remainder of the year, we are raising and tightening our full-year net sales guidance. Our Board's decision to initiate a quarterly dividend reflects the durability of our cash flow profile and the strength of our balance sheet. Guided by a disciplined approach to capital allocation, we will continue to prioritize investment in our business while returning capital to shareholders to drive long-term value creation.”

1) Non-GAAP measure - Refer to "Reconciliation of Non-GAAP Financial Measures” for a detailed reconciliation of these measures to the most directly comparable U.S. GAAP measure for historical periods, as applicable, and a discussion of why management believes these non-GAAP measures are useful.

Second Quarter 2026 Results

Versigent delivered second quarter 2026 net sales of $2,444 million, an increase of 10.8% compared to the second quarter of 2025. Adjusted Net Sales Growth¹ was approximately 5% year-over-year. Growth was driven by higher volumes in North America and Asia Pacific reflecting stronger customer demand despite lower global automotive production.

Net income attributable to Versigent increased to $118 million in the second quarter from $107 million in the prior-year quarter. Net income margin was 4.8%, down 10 basis points year-over-year, primarily due to higher interest expense and income tax expense in the second quarter of 2026. Diluted earnings per share was $1.64 and Adjusted Diluted EPS¹ was $1.92 for the second quarter of 2026.

Adjusted EBITDA¹ totaled $272 million, compared to $218 million in the prior year quarter. Adjusted EBITDA¹ margin was 11.1% compared to 9.9% in the prior-year quarter. Adjusted EBITDA¹ margin reflected disciplined operating execution and higher volumes, despite headwinds related to commodity costs.

Interest expense totaled $36 million, compared to $1 million in the second quarter of 2025. The increase was primarily attributable to the Company’s senior notes and credit facility issued in the first quarter of 2026.

Income tax expense for the quarter was $46 million, compared to $21 million in the prior-year period. The increase was primarily due to higher earnings in 2026 and a net unfavorable change in discrete tax items relative to the prior-year period.

Net cash provided by operating activities totaled $158 million, compared to $150 million in the prior-year period. Capital expenditures were $51 million, compared to $42 million in the prior-year quarter. Free Cash Flow¹ was $107 million, relatively flat year-over-year. Free Cash Flow¹ for the second quarter of 2026 included $22 million of separation-related costs.

Dividend

On August 3, the Company's Board of Directors declared an inaugural quarterly cash dividend of $0.13 per ordinary share, payable on September 18, 2026 to shareholders of record at the close of business on September 4, 2026.

The declaration and payment of future dividends are subject to the discretion of the Company’s Board of Directors and will depend on the Company’s financial condition, results of operations, cash requirements, and other factors deemed relevant by the Board of Directors.

Updated Full Year 2026 Guidance... (truncated)Measures” for definitions of Non-GAAP financial measures.

Conference Call and Webcast

Versigent’s management team will host a conference call to discuss its second quarter 2026 financial results today, Tuesday, August 4, 2026, at 9:00 a.m. Eastern Time.

A live webcast and related presentation materials will be available on Versigent’s Investor Relations website at ir.versigent.com. A replay of the webcast will be available on the same website approximately two hours after the call concludes.

To participate by telephone, please dial +1-800-330-6710 (U.S.) or +1-213-279-1505 (International) at least 15 minutes prior to the start of the call and reference the Versigent conference call. The conference ID number is 1768848.¹

About Versigent

Versigent is a global leader in the purposeful design and advanced manufacturing of low and high voltage electrical architectures. Building on a legacy of engineering excellence and trusted partnerships, Versigent delivers versatile, intelligent solutions engineered to unlock greater capabilities for our customers. Powering one in six passenger vehicles in production today, Versigent’s high performance signal, power, and data distribution systems are trusted by industry leaders across automotive, commercial vehicles, agriculture and energy storage. With engineering and manufacturing centers on four continents and operations in more than 25 countries, Versigent’s approximately 138,000 employees match global scale with regional responsiveness to deliver consistent quality and reliable performance connecting the world to faster, smarter and safer experiences. Visit www.versigent.com.

Use of Non‑GAAP Financial Measures

In addition to its reported results calculated in accordance with U.S. GAAP, the Company has included in this press release Adjusted Net Sales Growth, Adjusted EBITDA, Adjusted Net Income and Adjusted Diluted EPS, performance measures, and Free Cash Flow, a liquidity measure, that the Securities and Exchange Commission defines as “non-GAAP financial measures”. Adjusted Net Sales Growth represents the change in reported net sales relative to the comparable period, excluding the impact on net sales from currency exchange and commodity movements. Adjusted EBITDA represents net income (loss) attributable to Versigent before depreciation and amortization (including asset impairments), interest expense, income tax (expense) benefit, net (loss) income attributable to noncontrolling interest, other income (expense), net, equity income (loss), net of tax, restructuring, separation costs related to the Spin-Off, other acquisition and portfolio project costs (which includes costs incurred to integrate acquired businesses and to plan and execute product portfolio transformation actions, including business and product acquisitions and divestitures) and other special items. Adjusted EBITDA margin represents Adjusted EBITDA as a percentage of net sales. Adjusted Net Income represents net (loss) income attributable to Versigent before amortization, restructuring, separation costs related to the Spin-Off, other acquisition and portfolio project costs (which includes costs incurred to integrate acquired businesses and to plan and execute product portfolio transformation actions, including business and product acquisitions and divestitures) and other special items, including the tax impact thereon. Adjusted Diluted EPS represents Adjusted Net Income divided by the weighted average number of diluted shares outstanding for the period. Free Cash Flow represents net cash provided by (used in) operating activities less capital expenditures.

Management believes these non-GAAP financial measures are useful to both management and investors in their analysis of the Company’s financial position, results of operations and liquidity. In particular, management believes Adjusted Net Sales Growth, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS and Free Cash Flow are useful measures in assessing the Company’s ongoing financial performance that, when reconciled to the corresponding U.S. GAAP measure, provide improved comparability between periods through the exclusion of certain items that management believes are not indicative of the Company’s core operating performance and that may obscure underlying business results and trends. Management also uses these non-GAAP financial measures for internal planning and forecasting purposes.

Such non-GAAP financial measures are reconciled to the most directly comparable U.S. GAAP financial measures in the attached supplemental schedules at the end of this press release. Non-GAAP financial measures should not be considered in isolation or as a substitute for our reported results prepared in accordance with U.S. GAAP and, as calculated, may not be comparable to other similarly titled measures of other companies.

Financial statements

Income Statement

Three Months Ended June 30, — (Unaudited) (in millions, except per share amounts)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Net sales2,4442,2064,6564,230
Operating expenses:Cost of sales2,1231,9434,0913,718
Operating expenses:Selling, general and administrative100104197209
Operating expenses:Amortization111
Operating expenses:Restructuring254641
Operating expenses:Separation costs222487
Operating expenses:Total operating expenses2,2452,0754,3833,976
Operating expenses:Operating income199131273254
Operating expenses:Interest expense-36-1-41-3
Operating expenses:Other expense, net-6-7-1
Operating expenses:Income before income taxes and equity income157130225250
Operating expenses:Income tax expense-46-21-37-50
Operating expenses:Income before equity income111109188200
Operating expenses:Equity income, net of tax5398
Operating expenses:Net income116112197208
Operating expenses:Net (loss) income attributable to noncontrolling interest-2516
Operating expenses:Net income attributable to Versigent118107196202
Basic earnings per share:Basic earnings per share attributable to Versigent1.661.512.762.85
Basic earnings per share:Weighted average number of basic shares outstanding (1)70.970.8970.970.89
Diluted earnings per share:Diluted earnings per share attributable to Versigent1.641.512.752.85
Diluted earnings per share:Weighted average number of diluted shares outstanding (1)71.8870.8971.3970.89

Income Statement

Three Months Ended June 30, (in millions)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025Six Months Ended June 30, – 2025
Net income attributable to Versigent118107196202
Interest expense361413
Income tax expense46213750
Net (loss) income attributable to noncontrolling interest-2516
Depreciation and amortization5159112111
EBITDA249193387372
Other expense, net671
Equity income, net-5-3-9-8
Restructuring254641
Separation costs222487
Net gain on lease terminations-4
Other acquisition and portfolio project costs13
Adjusted EBITDA272218475416
Memo:Net sales2,4442,2064,6564,230
Memo:Net income margin4.8%4.9%4.2%4.8%
Memo:Adjusted EBITDA margin11.1%9.9%10.2%9.8%

Income Statement

Three Months Ended June 30, (in millions, except per share amounts)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Net income attributable to Versigent118107196202
Adjusting items:Amortization111
Adjusting items:Restructuring254641
Adjusting items:Separation costs222487
Adjusting items:Other acquisition and portfolio project costs13
Adjusting items:Asset impairments373
Adjusting items:Net gain on lease terminations-4
Adjusting items:Pension curtailment and settlement losses26
Adjusting items:Separation-related interest expense2
Adjusting items:Tax impact of adjusting items (1)-4-5-18-8
Adjusting items:Adjusted Net Income138134284249
Adjusting items:Weighted average number of diluted shares outstanding (2)71.8870.8971.3970.89
Adjusting items:Diluted earnings per share attributable to Versigent1.641.512.752.85
Adjusting items:Adjusted Diluted EPS1.921.893.983.51

Balance Sheet

CONDENSED CONSOLIDATED BALANCE SHEETS (in millions)

June 30, 2026 – (Unaudited)December 31, 2025
Current assets:Cash and cash equivalents554276
Current assets:Accounts receivable, net1,8771,567
Current assets:Inventories772772
Current assets:Other current assets337158
Current assets:Total current assets3,5402,773
Long-term assets:Property, net901901
Long-term assets:Operating lease right-of-use assets192168
Long-term assets:Investments in affiliates149143
Long-term assets:Intangible assets, net67
Long-term assets:Deferred tax assets443384
Long-term assets:Other long-term assets128109
Long-term assets:Total long-term assets1,8191,712
Long-term assets:Total assets5,3594,485
Current liabilities:Short-term debt15358
Current liabilities:Accounts payable1,6661,530
Current liabilities:Accrued liabilities713578
Current liabilities:Total current liabilities2,5322,166
Long-term liabilities:Long-term debt2,0713
Long-term liabilities:Pension benefit obligations214217
Long-term liabilities:Long-term operating lease liabilities144130
Long-term liabilities:Other long-term liabilities114121
Long-term liabilities:Total long-term liabilities2,543471
Long-term liabilities:Total liabilities5,0752,637
Shareholders’ equity:Ordinary shares, $0.01 par value per share, 1,200,000,000 shares authorized, 70,925,978 issued and 70,815,717 outstanding as of June 30, 20261

Cash Flow

Six Months Ended June 30, — (Unaudited) (in millions)

Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Net cash provided by operating activities194190
Cash flows from investing activities:Capital expenditures-117-79
Cash flows from investing activities:Net cash used in investing activities-117-79
Cash flows from financing activities:Net proceeds (repayments) under short-term debt agreements86-132
Cash flows from financing activities:Net repayments under long-term debt agreements-1
Cash flows from financing activities:Proceeds from issuance of senior notes and credit agreement, net of issuance costs2,063
Cash flows from financing activities:Cash distribution paid to Former Parent-1,894
Cash flows from financing activities:Net transfers (to) from Former Parent-47134
Cash flows from financing activities:Dividend payments of consolidated affiliates to minority shareholders-4
Cash flows from financing activities:Taxes withheld and paid on employees' restricted share awards-1
Cash flows from financing activities:Net cash provided by financing activities2031
Cash flows from financing activities:Effect of exchange rate fluctuations on cash and cash equivalents-215
Cash flows from financing activities:Increase in cash and cash equivalents278127
Cash flows from financing activities:Cash and cash equivalents at beginning of the period276201
Cash flows from financing activities:Cash and cash equivalents at end of the period554328

Cash Flow

Three Months Ended June 30, (in millions)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Net cash provided by operating activities158150194190
Capital expenditures-51-42-117-79
Free Cash Flow10710877111
Full release

Forward‑Looking Statements... (truncated)tions in the supply of raw materials and other supplies integral to our products; future significant public health crises and other global health crises and the measures taken in response thereto; a prolonged recession and/or a downturn in global automotive sales; the volatile global economic environment and geopolitical conditions, including conditions affecting the credit market and global inflationary pressures; our reliance on relationships with collaborative partners and other third parties for product development and such parties’ failure to perform; employee strikes and labor-related disruptions involving us or one or more of our customers affecting our operations; fluctuations in interest rates and foreign currency exchange rates; our failure to comply with the numerous laws and regulations to which we are subject; adverse developments affecting one or more of our suppliers; any adverse impact of legal proceedings and disputes in which we are involved; challenges to our historical and future tax positions by taxing authorities; an increase in our tax burden due to ongoing or future tax audits; our failure to attract and retain key² salaried employees and management personnel; our failure to manage the transition to a standalone public company; and our failure to achieve some or all of the benefits expected from the Spin-Off. Additional factors are discussed under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Versigent’s filings with the Securities and Exchange Commission, including those set forth in the Company’s Information Statement furnished with the Company’s Registration Statement on Form 10-12B/A filed on March 6, 2026. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect Versigent. It should be remembered that the price of the ordinary shares and any income from them can go down as well as up. Versigent disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events and/or otherwise, except as may be required by law.³

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Versigent earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.